An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993

AIDS

Volumn 10, Issue 3, 1996, Pages 299-309

  Chum, Hamza J ^a   O'Brien, Richard J ^b   Chonde, T Martin ^c   Graf, Petra ^a,b   Rieder, Hans L ^d  

^a Tanzania Natl TB and Leprosy Prog   (Tanzania)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c MUHIMBILI MEDICAL CENTRE   (Tanzania)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

AIDS; HIV infection; Sub Saharan Africa; Tuberculosis

Indexed keywords

BCG VACCINE; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIOLOGY; BACTERIUM CULTURE; BLOOD DONOR; COMPARATIVE STUDY; DEMOGRAPHY; DISEASE TRANSMISSION; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RELAPSE; RISK; SCREENING TEST; TANZANIA; TUBERCULOSIS; URBAN AREA;

EID: 0029911586     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199603000-00009     Document Type: Article

References (29)

1. Narain JP, Raviglione MC, Kochi A: HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tubercle Lung Dis 1992, 73:311-321.
2. De Cock KM, Sora B, Coulibaly IM, Lucas SB: Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992, 268:1581-1587.
3. Epidemiology Unit, National AIDS Control Programme: AIDS Surveillance Report No. 3. Dar es Salaam: Ministry of Health; 1990.
4. Killewo JZJ, Sandstrom A, Bredberg Raden U, Mhalu FS, Biberfeld G, Wall S: Incidence of HIV-1 infection among adults in the Kagera region of Tanzania. Int J Epidemiol 1993, 22:528-536.
5. Tanzania National AIDS Control Programme: HIV/AIDS/STD Surveillance Report No. 8. Das es Salaam: Ministry of Health; 1994.
6. Global Programme on AIDS: Recommendations for the selection and use of HIV antibody tests. WHO Wkly Epidemiol Rec 1992, 67:145-149.
7. Canetti G, Froman S, Grosset J, et al.: Mycobacteria: laboratory methods for testing drug susceptibility and resistance. Bull WHO 1963, 29:565-578.
8. Lilienfeld AM: Retrospective and cross-sectional studies. In foundations of Epidemiology. New York: Oxford University Press; 1976:192-193.
9. Elliott AM, Luo N, Tembo G, et al.: Impact of HIV on tuberculosis in Zambia: a cross sectional sludy. BMJ 1990, 301:412-415.
10. Elliott AM, Namaambo K, Allen BW, et al.: Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tubercle Lung Dis 1993, 74:191-194.
11. Githui W, Nunn P, Juma E, et al.: Cohort study of HIV-positive and HIV-negative tuberculosis patients, Nairobi, Kenya: comparison of bacteriological results. Tubercle Lung Dis 1992, 73:203-209.
12. Hawken M, Nunn P, Gathua S, et al.: Increased recurrence of tuberculosis in HIV-1 infected patients in Kenya. Lancet 1993, 342:332-337.
13. Okwera A, Whalen C, Byekwaso F, et al: Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. Lancet 1994, 344:1323-1328.
14. Perriëns JH, St Louis ME, Mukadi YB, et al.: Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995, 332:779-784.
15. Centers for Disease Control: Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR 1991, 40:585-591.
16. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA: Tuberculosis in New York City - turning the tide. New Engl J Med 1995, 333:229-233.
17. Glynn JR, Jenkins PA, Fine PEM, et al.: Pattern of initial and acquired antituberculosis drug resistance in Karonga District, Malawi. Lancet 1995, 345:907-910.
18. Braun MM, Kilburn JO, Smithwick RW, et al.: HIV infection and primary resistance to antituberculosis drugs in Abidjan, Côte d'Ivoire. AIDS 1992, 6:1327-1330.
19. Ridzon R, Taylor J, Kelly M, Valway S, Geiter L, Onorato I: Risk of rifampin mono-resistant tuberculosis associated with human immunodeficiency virus infection. Presented at the Annual Meeting of the IUATLD. Paris, September 1995.
20. Nolan CM, Williams DL, Cave MD, et al.: Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am J Respir Crit Care Med 1995, 152:1067-1071.
21. Centers for Disease Control: Primary resistance to antituberculosis drugs - United States. MMWR 1983, 32:521-523.
22. Tanzania National Tuberculosis and Leprosy Programme: Summary Reports. Dar es Salaam: Ministry of Health; 1991-1995.
23. Long R, Scalcini M, Manfreda J, et al.: Impact of human immunodeficiency virus type 1 on tuberculosis in rural Haiti. Am Rev Respir Dis 1991, 143:69-73.
24. De Cock KM, Gnaore E, Adjorlolo G, et al.: Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast. BMJ 1991, 302:496-499.
25. Aisu T, Raviglione MC, Narain JP, et al.: Monitoring HIV-associated tuberculosis in Uganda. World Congress on Tuberculosis. Bethesda, November 1992 [abstract 43-D].
26. Borgdorff M, Barongo L, van Jaarsveld E, et al.: Sentinel surveillance for HIV-1 infection: how representative are blood donors, outpatients with fever, anaemia, or sexually transmitted diseases, and antenatal clinic attenders in Mwanza Region, Tanzania? AIDS 1993, 7:567-572.
27. van den Broek J, Borgdorff MW, Pakker NG, et al: HIV-1 infection as a risk factor for the development of tuberculosis: a case-control study in Tanzania. Int J Epidemiol 1993, 22:1159-1165.
28. Richards SB, St Louis ME, Niegurg P, et al.: Impact of the HIV epidemic on trends in tuberculosis in Abidjan, Côte d'Ivoire. Tubercle Lung Dis 1995, 76:11-16.
29. Tanzania National AIDS Control Programme: HIV/AIDS/STD Surveillance Report No. 9. Dar es Salaam: Ministry of Health; 1995.